The authors thank Carlo Pellizzari from CenterVue SpA for technical support. CenterVue SpA, Padua, Italy, has provided research material (S-MAIA) for this study. CenterVue had no role in the design or conduct of the experiments.
Supported by the German Scholars Organization/Else Kröhner Fresenius Stiftung (GSO/EKFS 16).
Disclosure: S.G. Welker, Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F); M. Pfau, Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F); M. Heinemann, Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F); S. Schmitz-Valckenberg, Heidelberg Engineering (F, R), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F), Allergan (F, R), Alcon/Novartis (F, R), Bioeq/Fermycon (F), Genentech/Roche (F, R), Bayer (F, R); F.G. Holz, Heidelberg Engineering (F, C, R), Optos (F), Carl Zeiss MedicTec (F, C), CenterVue (F), Allergan (F, R), Alcon/Novartis (F, R), Genentech/Roche (F, R), Bayer (F, R), Acucela (F, R), Boehringer Ingelheim (F, R); R.P. Finger, Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F), Bayer (C), Novartis (C), Santen (C), Opthea (C), Novelion (C), Retina Implant (C), Oxford Innovation (C), Novartis (F)